Aveanna Healthcare Holdings Inc. (AVAH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Aveanna Healthcare Holdings Inc. (AVAH) trades at $6.35 with AI Score 52/100 (Hold). Aveanna Healthcare Holdings Inc. Market cap: 2B, Sector: Healthcare.
Last analyzed: Feb 9, 2026Aveanna Healthcare Holdings Inc. (AVAH) Healthcare & Pipeline Overview
Aveanna Healthcare (AVAH) offers a compelling investment in the growing home healthcare market, providing diversified services from pediatric care to hospice, capitalizing on the shift towards in-home care and reducing healthcare costs with a patient-centered approach and a 3.3% profit margin.
Investment Thesis
Aveanna Healthcare presents a notable research candidate due to its strategic positioning in the expanding home healthcare market. The increasing preference for in-home care, coupled with the rising costs of institutional healthcare, creates a favorable environment for Aveanna's diversified service offerings. With a market capitalization of $1.64 billion and a P/E ratio of 21.74, Aveanna demonstrates solid financial performance. Key value drivers include the growth of its Private Duty Services (PDS) segment, driven by the increasing demand for pediatric home care, and the expansion of its Home Health & Hospice (HHH) segment, capitalizing on the aging population and the desire for end-of-life care at home. The company's Medical Solutions (MS) segment provides a steady revenue stream through the provision of essential medical supplies. Aveanna's patient-centered approach and focus on reducing healthcare costs position it for sustained growth and profitability.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $1.64 billion reflects investor confidence in Aveanna's market position.
- P/E ratio of 21.74 indicates a reasonable valuation relative to earnings.
- Gross margin of 33.5% demonstrates efficient cost management and pricing strategies.
- Profit margin of 3.3% showcases the company's ability to generate profit from its revenue.
- Beta of 2.06 suggests higher volatility compared to the market, potentially offering higher returns but also increased risk.
Competitors & Peers
Strengths
- Diversified service offerings across the home healthcare continuum.
- Established reputation for providing high-quality, patient-centered care.
- Strong relationships with managed care organizations and government payers.
- Geographic reach across multiple states in the United States.
Weaknesses
- Exposure to regulatory changes and reimbursement pressures.
- Reliance on government funding and managed care contracts.
- Competition from other home healthcare providers.
- Potential for labor shortages and increased labor costs.
Catalysts
- Increasing demand for home healthcare services due to the aging population.
- Shift towards value-based care models that reward providers for delivering high-quality, cost-effective care.
- Potential for strategic acquisitions to expand geographic reach and service offerings.
- Integration of technology solutions to improve efficiency and patient outcomes.
Risks
- Changes in government regulations and reimbursement policies could negatively impact revenue.
- Increased competition from other home healthcare providers could erode market share.
- Economic downturns could reduce demand for home healthcare services.
- Labor shortages and increased labor costs could impact profitability.
Growth Opportunities
- Growth opportunity 1: Expansion of Pediatric Services: The demand for pediatric home healthcare is increasing due to the rising number of children with complex medical needs. Aveanna can capitalize on this trend by expanding its Private Duty Services (PDS) segment, offering specialized nursing care, therapy services, and pediatric day healthcare centers. This market segment is projected to grow at an annual rate of 6-8% over the next five years, presenting a significant opportunity for Aveanna to increase its market share and revenue.
- Growth opportunity 2: Strategic Acquisitions: Aveanna can pursue strategic acquisitions of smaller home healthcare providers to expand its geographic reach and service offerings. By acquiring companies with complementary services or a strong presence in specific regions, Aveanna can accelerate its growth and enhance its competitive position. The home healthcare market is fragmented, providing ample opportunities for consolidation. Successful acquisitions can lead to increased revenue, cost synergies, and improved market penetration.
- Growth opportunity 3: Technology Integration: Investing in technology solutions, such as telehealth platforms and remote patient monitoring systems, can improve the efficiency and effectiveness of Aveanna's services. Telehealth can enable remote consultations, medication management, and patient education, while remote monitoring can provide real-time data on patients' health status. These technologies can enhance patient outcomes, reduce costs, and improve caregiver productivity, driving growth and profitability.
- Growth opportunity 4: Focus on Value-Based Care: As the healthcare industry shifts towards value-based care models, Aveanna can position itself as a leader in delivering high-quality, cost-effective care. By demonstrating improved patient outcomes and reduced healthcare costs, Aveanna can attract contracts with managed care organizations and government payers. This requires investing in data analytics, care coordination, and quality improvement initiatives. Success in value-based care can lead to increased patient volume, higher reimbursement rates, and enhanced brand reputation.
- Growth opportunity 5: Expansion of Hospice Services: With the aging population and the increasing prevalence of chronic diseases, the demand for hospice care is expected to grow significantly. Aveanna can expand its Home Health & Hospice (HHH) segment by offering comprehensive hospice services, including palliative care, pain management, and emotional support for patients and their families. This market segment offers attractive growth opportunities, as hospice care is often reimbursed at higher rates than other home healthcare services.
Opportunities
- Expansion of services into new geographic markets.
- Strategic acquisitions of smaller home healthcare providers.
- Integration of technology solutions to improve efficiency and patient outcomes.
- Focus on value-based care models to attract contracts with managed care organizations.
Threats
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns that could reduce demand for home healthcare services.
- Potential for lawsuits and regulatory investigations.
Competitive Advantages
- Diversified service offerings across the home healthcare continuum.
- Strong relationships with managed care organizations and government payers.
- Established reputation for providing high-quality, patient-centered care.
- Geographic reach across multiple states in the United States.
About AVAH
Aveanna Healthcare Holdings Inc., established in 2016 and headquartered in Atlanta, Georgia, operates as a diversified home care platform. The company was founded with the mission of providing high-quality, patient-centered care in the comfort of patients' homes, thereby minimizing the need for expensive hospital stays and institutional care. Aveanna's services span a wide spectrum, including private duty nursing (PDN), adult home health and hospice care, home-based pediatric therapy, and enteral nutrition services. These services are delivered through three primary segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment focuses on in-home skilled nursing for medically fragile children, nursing services in schools, pediatric day healthcare centers, and therapy services. The HHH segment provides skilled nursing, therapy, and hospice care to adults. The MS segment supplies enteral nutrition products. Aveanna's commitment to patient-centered care and its diversified service offerings position it as a key player in the evolving healthcare landscape, emphasizing cost-effective and personalized solutions.
What They Do
- Provides private duty nursing (PDN) for medically fragile children.
- Offers adult home health and hospice care services.
- Delivers home-based pediatric therapy services, including physical, occupational, and speech therapy.
- Supplies enteral nutrition products to adults and children.
- Operates pediatric day healthcare centers.
- Provides nursing services in school settings.
Business Model
- Generates revenue through providing skilled nursing and therapy services in patients' homes.
- Earns income from the sale of enteral nutrition supplies and other medical products.
- Contracts with managed care organizations, government payers, and private insurance companies for reimbursement of services.
- Operates on a fee-for-service basis, with rates varying based on the type and duration of services provided.
Industry Context
Aveanna Healthcare operates within the growing home healthcare industry, which is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The market is highly competitive, with players ranging from large national providers to smaller regional and local agencies. Aveanna differentiates itself through its diversified service offerings, encompassing pediatric care, adult home health, and medical solutions. The industry is expected to continue growing at a steady pace, fueled by technological advancements and increasing demand for cost-effective and patient-centered care. Competitors include ACHC (Acadia Healthcare), ADUS (Addus HomeCare), ARDT (Ardent Health Services), ASTH (Ascension Health), and BKD (Brookdale Senior Living), each with varying focuses within the healthcare spectrum.
Key Customers
- Medically fragile children requiring skilled nursing care.
- Adults needing home health services, including skilled nursing, therapy, and hospice care.
- Patients requiring enteral nutrition support.
- Families seeking in-home care for their loved ones.
Financials
Chart & Info
Aveanna Healthcare Holdings Inc. (AVAH) stock price: $6.35 (-0.26, -3.89%)
Latest News
-
Aveanna Healthcare Holdings' (NASDAQ:AVAH) Promising Earnings May Rest On Soft Foundations
Yahoo! Finance: AVAH News · Mar 27, 2026
-
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
Yahoo! Finance: AVAH News · Mar 26, 2026
-
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5
benzinga · Mar 25, 2026
-
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Lowers Price Target to $9
benzinga · Mar 23, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AVAH.
Price Targets
Consensus target: $10.50
MoonshotScore
What does this score mean?
The MoonshotScore rates AVAH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Aveanna Healthcare Holdings' (NASDAQ:AVAH) Promising Earnings May Rest On Soft Foundations
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Lowers Price Target to $9
Common Questions About AVAH (Healthcare)
What does Aveanna Healthcare Holdings Inc. do?
Aveanna Healthcare Holdings Inc. is a diversified home care platform company that provides a range of services, including private duty nursing, adult home health and hospice, home-based pediatric therapy, and enteral nutrition services. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). Aveanna's patient-centered care delivery platform allows patients to remain in their homes, minimizing the overutilization of high-cost care settings, such as hospitals. The company focuses on providing high-quality, cost-effective care to patients of all ages.
Is AVAH stock worth researching?
AVAH stock presents a mixed investment profile. The company operates in a growing industry with increasing demand for home healthcare services. Aveanna's diversified service offerings and patient-centered approach position it well for long-term growth. However, investors may want to evaluate the company's exposure to regulatory changes, reimbursement pressures, and competition. With a market cap of $1.64B and a P/E ratio of 21.74, AVAH's valuation appears reasonable, but potential investors should carefully evaluate the company's financial performance and growth prospects before making a decision.
What are the main risks for AVAH?
Aveanna Healthcare faces several key risks. Changes in government regulations and reimbursement policies could negatively impact the company's revenue and profitability. Increased competition from other home healthcare providers could erode market share and pricing power. Economic downturns could reduce demand for home healthcare services, particularly discretionary services. Labor shortages and increased labor costs could impact the company's ability to provide services and maintain profitability. Additionally, potential lawsuits and regulatory investigations could result in financial penalties and reputational damage.
What are the key factors to evaluate for AVAH?
Aveanna Healthcare Holdings Inc. (AVAH) currently holds an AI score of 52/100, indicating moderate score. The stock trades at a P/E of 6.0x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $10.50 (+65% from $6.35). Key strength: Diversified service offerings across the home healthcare continuum. Primary risk to monitor: Changes in government regulations and reimbursement policies could negatively impact revenue. This is not financial advice.
How frequently does AVAH data refresh on this page?
AVAH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AVAH's recent stock price performance?
Recent price movement in Aveanna Healthcare Holdings Inc. (AVAH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $10.50 implies 65% upside from here. Notable catalyst: Diversified service offerings across the home healthcare continuum. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AVAH overvalued or undervalued right now?
Determining whether Aveanna Healthcare Holdings Inc. (AVAH) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 6.0. Analysts target $10.50 (+65% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AVAH?
Before investing in Aveanna Healthcare Holdings Inc. (AVAH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.